Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FORGE Life Science announces antiviral compounds

June 6, 2016

Achaogen awarded funding for phase III EPIC study

June 6, 2016

NanoViricides enters partnership to further FluCide-I program

June 3, 2016

GeoVax's Ebola vaccine demonstrates complete protection against EBV challenge

June 2, 2016

Actelion Pharmaceuticals patents antibacterials

June 2, 2016

FDA grants fast track designation for VT-1129

June 2, 2016

FDA approves Teflaro in pediatric patients

June 1, 2016

Soligenix's SGX-943 gets FDA fast track designation

June 1, 2016

EMA committee recommends approval of Epclusa for hepatitis C

May 30, 2016

FORGE Life Science develops antivirals

May 30, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...